Tag:

personalized medicine

Latest Headlines

Latest Headlines

Harvard's Wyss Institute unveils human 'gut-on-a-chip'

Scientists at Harvard's Wyss Institute have been working on human "organs-on-a-chip" technology in order to pioneer new therapies and predict drug safety in the lab. Now a team at the institute has leveraged their proprietary technology to engineer a model of human intestinal inflammation and bacterial overgrowth in a human "gut-on-a-chip."

An experimental class of drugs alters cell metabolism and may prevent tumor growth

Researchers from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center and Massachusetts General Hospital have discovered that a class of experimental drugs used for altering cell metabolism also works in mice to reduce cancers linked to changes in the same gene.

BioNano Genomics hooks $68.4M for tech that spots 'inaccessible genome'

Gene mapping outfit BioNano Genomics is hoping to set itself apart in the personalized medicine market, where a number of gene sequencing competitors are lining up. To help it get its technology to patients, the San Diego-based company has raised $68.4 million in a series C financing round, according to a regulatory filing.

BioNano Genomics hooks $68.4M for tech that spots 'inaccessible genome'

Gene mapping outfit BioNano Genomics is hoping to set itself apart in the personalized medicine market, where a number of gene sequencing competitors are lining up. To help it get its technology to patients, the San Diego-based company has raised $68.4 million in a series C financing round, according to a regulatory filing.

SV Bio changes name to Lifecode, plans rollout of NGS cancer assay

Alongside the launch of a next generation sequencing-based oncology assay, Silicon Valley Biosystems is also rolling out a new name to reflect its mission of providing practical genetic information to patients.

SV Bio changes name to Lifecode, plans rollout of NGS cancer assay

Alongside the launch of a next generation sequencing-based oncology assay, Silicon Valley Biosystems is also rolling out a new name to reflect its mission of providing practical genetic information to patients.

LabCorp's $85M LipoScience buy deepens its dive into personalized Dx tests

LabCorp said it will pay more than $85 million in cash for LipoScience in a bid to grow its own roster of personalized diagnostic tests. The deal, which breaks down to $5.25 per share, is yet another sign that personalized medicine is becoming more ubiquitous in the marketplace.

LabCorp's $85M LipoScience buy deepens its dive into personalized Dx tests

LabCorp said it will pay more than $85 million in cash for LipoScience in a bid to grow its own roster of personalized diagnostic tests. The deal, which breaks down to $5.25 per share, is yet another sign that personalized medicine is becoming more ubiquitous in the marketplace.

NIH launches study of 'exceptional responders' to cancer therapies

The National Cancer Institute has launched a three to four year broad-based study of exceptional responders--patients who have had particularly good outcomes on cancer therapies as compared to their peers. The initiative was first considered a few years ago when it started to become easier to determine the molecular basis of why a particular patient's cancer responds to a molecularly targeted drug, but it is only being undertaken now.

GeneCentric grabs $5M Series A to advance testing for personalized cancer treatments

Startup GeneCentric Diagnostics pulled in $5 million in new Series A financing, according to reports from The Herald-Sun and Dow Jones VentureWire, among other media organizations. The money will help the North Carolina startup advance further development of gene-based diagnostic products designed to enable personalized treatments.